Supercede and CyberCube Partner to Power Faster, Smarter Cyber Reinsurance Placements
LONDON–(BUSINESS WIRE)–CyberCube, the market leader in cyber risk analytics, and Supercede, the global reinsurance technology platform, have announced... Read more.
Ohmium’s Comprehensive and Modular Hydrogen Solution Achieves a Compact Horizontal Footprint of 29.7 m²/MW, Including Maintenance and Access Areas
New design sets industry standards for land usage and scope inclusivity NEWARK, Calif.–(BUSINESS WIRE)–#HydrogenInnovation–Ohmium International,... Read more.
IFA 2025: Discover the future of floor care with Tineco
From September 5 to 9, technology and home care come together at IFA in Berlin. Tineco will showcase its latest products at the international technology trade fair.... Read more.
Vonage Named Best CPaaS Provider
Vonage’s AI-enabled Communications APIs provide developers and businesses with the ability to create advanced customer experience solutions HOLMDEL, N.J.–(BUSINESS... Read more.
European Commission Authorizes Twice-Yearly Yeytuo® (Lenacapavir) for HIV Prevention
– Yeytuo® is the First and Only European Commission (EC)-Authorized HIV PrEP Option Offering 6 Months of Protection – – Accelerated EC Decision Comes After... Read more.
Winebow Renews National Partnership With Provi to Advance Digital Trade Strategy
Company drives deeper engagement with licensed retailers through its digital portfolio in 17 markets. GLEN ALLEN, Va. & CHICAGO–(BUSINESS WIRE)–Winebow,... Read more.
Tineco to Unveil Its Next Wave of Smart Home Innovations at IFA 2025
BERLIN–(BUSINESS WIRE)–Smart home pioneer Tineco is returning to IFA Berlin (September 5–9, 2025), ready to showcase its latest breakthroughs designed... Read more.
NHOA Energy welcomes Western Australia’s Deputy Premier at its Milan headquarters
MILAN–(BUSINESS WIRE)–Yesterday, NHOA Energy had the privilege of welcoming the Hon. Rita Saffioti, Deputy Premier of Western Australia, Treasurer, Minister... Read more.
Calluna Pharma Announces Initiation of Phase 2 AURORA Study of CAL101 for Idiopathic Pulmonary Fibrosis
CAL101 is a first-in-class monoclonal antibody targeting S100A4, a damage-associated molecular pattern (DAMP) protein associated with serious and life-threatening... Read more.
Interim Financial Results 2025: Cadeler delivers financial performance above expectations
COPENHAGEN, Denmark–(BUSINESS WIRE)–Today, Cadeler A/S (“Cadeler” and, together with its subsidiaries, the “Group”) has published its interim... Read more.